Adent Capital Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Adent Capital General Information
Description
Khiron Life Sciences Corp is a Canada based company involved in cultivating, producing, and distributing THC (tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. Some of the potential uses for medicinal cannabis are disease treatment, pain relief, and disease prevention, including: treatment of epilepsy; slow cell damage in diabetes glaucoma, lower intraocular pressure; treatment of Tourette syndrome among others.
Contact Information
Corporate Office
- 67 Yonge Street
- Unit 903
- Toronto, Ontario M5E 1J8
- Canada
Corporate Office
- 67 Yonge Street
- Unit 903
- Toronto, Ontario M5E 1J8
- Canada
Adent Capital Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Adent Capital FAQs
-
When was Adent Capital founded?
Adent Capital was founded in 2012.
-
Where is Adent Capital headquartered?
Adent Capital is headquartered in Toronto, Canada.
-
What industry is Adent Capital in?
Adent Capital’s primary industry is Special Purpose Acquisition Company (SPAC).
-
Is Adent Capital a private or public company?
Adent Capital is a Private company.
-
What is Adent Capital’s current revenue?
The current revenue for Adent Capital is .
-
How much funding has Adent Capital raised over time?
Adent Capital has raised $305K.
-
When was Adent Capital acquired?
Adent Capital was acquired on 12-Jan-2018.
-
Who acquired Adent Capital?
Adent Capital was acquired by Khiron Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process